The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Guest Editorial

New leadership, vision for the Worldwide Innovative Network Consortium in precision oncology

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

From the time of its inception, the Worldwide Innovative Network (WIN) Consortium in precision cancer medicine has had a bold mission to significantly improve survival of patients with cancer across the world through international collaboration.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Byline
Wafik S. El-Deiry, MD, PhD, FACP
Chair, WIN; Director, Legorreta Cancer Center at Brown University; Attending physician, hematology/oncology, Lifespan Cancer Institute; Associate dean, oncologic sciences, Warren Alpert Medical School, Brown University
Table of Contents

YOU MAY BE INTERESTED IN

Guest Editorial

Biomarker-driven innovation: What the FDA’s evolving strategy means for oncology

As oncology enters a new era of precision medicine, the Food and Drug Administration’s evolving biomarker strategy aims to ensure that life-saving therapies are tailored to individual patient needs, fostering safer and more effective treatments.  Historically, therapies were approved with broad indications based on overall efficacy, even when outcomes for biomarker-positive and -negative patients were...

By Harpreet Singh
Byline
Wafik S. El-Deiry, MD, PhD, FACP
Chair, WIN; Director, Legorreta Cancer Center at Brown University; Attending physician, hematology/oncology, Lifespan Cancer Institute; Associate dean, oncologic sciences, Warren Alpert Medical School, Brown University
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account